Join
Live feed
·
INSIDERFilingvia Quantisnow
Eliem Therapeutics Inc logo

EVP, R&D AND CSO Morisset Valerie sold $356,500 worth of shares (50,000 units at $7.13), decreasing direct ownership by 20% to 202,306 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELYM· Eliem Therapeutics Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELYM (Eliem Therapeutics Inc) and more on Quantisnow.